ArticleInternational urology and nephrology2024

Shuangshi Tonglin Capsule treats benign prostatic hyperplasia through the ROS/NLRP3 signaling pathway.

Ziqiang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.